References
1. Coughlan C., Ledger W., Wang Q. et al. Recurrent implantation failure: definition and management // Reprod Biomed Online. — 2014. — Vol. 28(1). — P. 14–38.
2. Kitaya K., Takeuchi T., Mizuta S. et al. Endometritis: new time, new concepts // Fertility and Sterility. — 2018. — Vol. 110(3). — P. 344–350.
3. Liu Y., Chen X., Huang J. et al. Chronic endometritis and infertility // Am J Reprod Immunol. — 2019. — Vol. 82(6). — P. e13132.
4. Bashiri A., Halper K., Orvieto R. Recurrent implantation failure-update overview on etiology // J Assist Reprod Genet. — 2018. — Vol. 35. — P. 343–358.
5. Vitagliano A., Noventa M., Gizzo S. et al. Chronic endometritis and implantation failure // Fertility and Sterility. — 2020. — Vol. 114(6). — P. 1231–1240.
6. Elvis A.M., Ekta J.S. Ozone therapy: a clinical review // J Nat Sci Biol Med. — 2011. — Vol. 2(1). — P. 66–70.
7. Bocci V. Ozone: A New Medical Drug. — Dordrecht: Springer, 2011.ESHRE Guideline Group on RIF. Recurrent implantation failure guideline // Human Reproduction Open. — 2023.
8. ASRM Practice Committee. Role of endometrial receptivity testing // Fertility and Sterility. — 2024.
9. Simon A., Laufer N. Repeated implantation failure // Fertility and Sterility. — 2012. — Vol. 97(5). — P. 1036–1043.
10. Franasiak J.M., Scott R.T. Immunological aspects of implantation // Fertility and Sterility. — 2015. — Vol. 104(6). — P. 1346–1353.
11. Craciunas L., Gallos I., Chu J. et al. Conventional and modern markers of endometrial receptivity // Hum Reprod Update. — 2019. — Vol. 25(2). — P. 202–223.